{"id":19061,"date":"2018-08-21T22:28:21","date_gmt":"2018-08-22T01:28:21","guid":{"rendered":"https:\/\/www.tiabeth.com.br\/?p=19061"},"modified":"2018-08-21T22:28:21","modified_gmt":"2018-08-22T01:28:21","slug":"anvisa-aprova-medicamento-para-diabetes","status":"publish","type":"post","link":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/","title":{"rendered":"Anvisa aprova medicamento para diabetes"},"content":{"rendered":"<figure id=\"attachment_19062\" aria-describedby=\"caption-attachment-19062\" style=\"width: 1000px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg\"><img loading=\"lazy\" class=\"size-full wp-image-19062\" src=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg\" alt=\"\" width=\"1000\" height=\"650\" srcset=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg 1000w, https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic-300x195.jpg 300w, https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic-768x499.jpg 768w, https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic-765x496.jpg 765w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><\/a><figcaption id=\"caption-attachment-19062\" class=\"wp-caption-text\">Prote\u00e7\u00e3o cardiovascular \u00e9 destaque do tratamento, segundo fabricante<\/figcaption><\/figure>\n<p>A Anvisa aprovou um novo medicamento para Diabetes Tipo 2. Em testes que avaliaram sua seguran\u00e7a cl\u00ednica, o Ozempic (semaglutida) apresentou efic\u00e1cia na redu\u00e7\u00e3o da hemoglobina glicada (HbA1c), do peso e das complica\u00e7\u00f5es cardiovasculares. O medicamento, que consiste em uma solu\u00e7\u00e3o injet\u00e1vel, deve ser aplicada semanalmente. \u00c9 indicado para pacientes adultos com dificuldade em controlar a doen\u00e7a.<\/p>\n<p>\u201cAl\u00e9m de diminuir rapidamente a glicemia e a hemoglobina glicada, reduz press\u00e3o arterial, triglic\u00e9rides e a perda de prote\u00edna pelo rim\u201d, afirma Freddy Goldberg Eliaschewitz, Assessor Cient\u00edfico da Sociedade Brasileira de Diabetes (SBD). Dentre os resultados, destacam-se as redu\u00e7\u00f5es nas ocorr\u00eancias de acidente vascular cerebral (AVC) e infarto do mioc\u00e1rdio (IAM), ambos n\u00e3o fatais: 39% e 26%, respectivamente. \u201cQuem \u00e9 tratado com essa droga tem uma redu\u00e7\u00e3o de 26% na taxa de desfecho combinado por morte cardiovascular&#8221;, completa Goldberg.<\/p>\n<p>Segundo A investigadora do ensaio, Rosangela R\u00e9a &#8211; membro do Departamento de Doen\u00e7as Cardiovasculares da SBD &#8211; o resultado foi excelente. \u201cO medicamento confirmou as redu\u00e7\u00f5es expressivas de hemoglobina glicada e peso j\u00e1 demonstrada em estudos anteriores, e no curto per\u00edodo de pouco mais de dois anos demonstrou benef\u00edcio cardiovascular\u201d, refor\u00e7a.<\/p>\n<p>Esse benef\u00edcio \u00e9 o principal destaque do Ozempic, sobretudo considerando que, de acordo com a Federa\u00e7\u00e3o Internacional de Diabetes (IDF), idosos com diabetes tipo 2 t\u00eam risco de 3 a 4 vezes maior de morrer em decorr\u00eancia de doen\u00e7as cardiovasculares. Segundo uma estimativa da Associa\u00e7\u00e3o Americana de Diabetes (ADA), na popula\u00e7\u00e3o entre 51 e 69 anos, a doen\u00e7a est\u00e1 ligada a 1\/3 dos casos de AVC e 1\/4 das doen\u00e7as coronarianas.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/odia.ig.com.br\/vida-saudavel\/2018\/08\/5568295-anvisa-aprova-medicamento-para-diabetes.html\" target=\"_blank\" rel=\"noopener\">https:\/\/odia.ig.com.br\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Anvisa aprovou um novo medicamento para Diabetes Tipo 2. Em testes que avaliaram sua seguran\u00e7a cl\u00ednica, o Ozempic (semaglutida) apresentou efic\u00e1cia na redu\u00e7\u00e3o da hemoglobina glicada (HbA1c), do peso e das complica\u00e7\u00f5es cardiovasculares. O medicamento, que consiste em uma solu\u00e7\u00e3o injet\u00e1vel, deve ser aplicada semanalmente. \u00c9 indicado para pacientes adultos com dificuldade em controlar [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":19062,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[19,196,187],"tags":[28,1195,4620,35,221],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Anvisa aprova medicamento para diabetes - TiaBeth.com<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\" \/>\r\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Anvisa aprova medicamento para diabetes - TiaBeth.com\" \/>\r\n<meta property=\"og:description\" content=\"A Anvisa aprovou um novo medicamento para Diabetes Tipo 2. Em testes que avaliaram sua seguran\u00e7a cl\u00ednica, o Ozempic (semaglutida) apresentou efic\u00e1cia na redu\u00e7\u00e3o da hemoglobina glicada (HbA1c), do peso e das complica\u00e7\u00f5es cardiovasculares. O medicamento, que consiste em uma solu\u00e7\u00e3o injet\u00e1vel, deve ser aplicada semanalmente. \u00c9 indicado para pacientes adultos com dificuldade em controlar [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\" \/>\r\n<meta property=\"og:site_name\" content=\"TiaBeth.com\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/tiabethcom\" \/>\r\n<meta property=\"article:published_time\" content=\"2018-08-22T01:28:21+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\r\n\t<meta property=\"og:image:height\" content=\"650\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"nlimonge\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:site\" content=\"@tiabethcom\" \/>\r\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"nlimonge\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982\",\"name\":\"Raquel Limonge\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg\",\"contentUrl\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg\",\"width\":856,\"height\":856,\"caption\":\"Raquel Limonge\"},\"logo\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/tiabethcom\",\"https:\/\/www.instagram.com\/raqueltiabeth\",\"https:\/\/twitter.com\/https:\/\/www.twitter.com\/tiabethcom\"]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#website\",\"url\":\"https:\/\/www.tiabeth.com.br\/\",\"name\":\"TiaBeth.com\",\"description\":\"O maior conte\u00fado sobre diabetes da l\u00edngua portuguesa\",\"publisher\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.tiabeth.com.br\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#primaryimage\",\"url\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg\",\"contentUrl\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg\",\"width\":1000,\"height\":650,\"caption\":\"Prote\u00e7\u00e3o cardiovascular \u00e9 destaque do tratamento, segundo fabricante\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\",\"url\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\",\"name\":\"Anvisa aprova medicamento para diabetes - TiaBeth.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#primaryimage\"},\"datePublished\":\"2018-08-22T01:28:21+00:00\",\"dateModified\":\"2018-08-22T01:28:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/www.tiabeth.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa aprova medicamento para diabetes\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\"},\"author\":{\"name\":\"nlimonge\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b\"},\"headline\":\"Anvisa aprova medicamento para diabetes\",\"datePublished\":\"2018-08-22T01:28:21+00:00\",\"dateModified\":\"2018-08-22T01:28:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/\"},\"wordCount\":315,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982\"},\"image\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg\",\"keywords\":[\"diabetes\",\"inje\u00e7\u00e3o\",\"ozempic\",\"tipo 2\",\"tratamento\"],\"articleSection\":[\".Not\u00edcia\",\"Medicamento\",\"Tipo 2\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b\",\"name\":\"nlimonge\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g\",\"caption\":\"nlimonge\"},\"url\":\"https:\/\/www.tiabeth.com.br\/index.php\/author\/nlimonge\/\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa aprova medicamento para diabetes - TiaBeth.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa aprova medicamento para diabetes - TiaBeth.com","og_description":"A Anvisa aprovou um novo medicamento para Diabetes Tipo 2. Em testes que avaliaram sua seguran\u00e7a cl\u00ednica, o Ozempic (semaglutida) apresentou efic\u00e1cia na redu\u00e7\u00e3o da hemoglobina glicada (HbA1c), do peso e das complica\u00e7\u00f5es cardiovasculares. O medicamento, que consiste em uma solu\u00e7\u00e3o injet\u00e1vel, deve ser aplicada semanalmente. \u00c9 indicado para pacientes adultos com dificuldade em controlar [&hellip;]","og_url":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/","og_site_name":"TiaBeth.com","article_publisher":"https:\/\/www.facebook.com\/tiabethcom","article_published_time":"2018-08-22T01:28:21+00:00","og_image":[{"width":1000,"height":650,"url":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg","type":"image\/jpeg"}],"author":"nlimonge","twitter_card":"summary_large_image","twitter_site":"@tiabethcom","twitter_misc":{"Escrito por":"nlimonge","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Person","Organization"],"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982","name":"Raquel Limonge","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/","url":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg","contentUrl":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg","width":856,"height":856,"caption":"Raquel Limonge"},"logo":{"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/"},"sameAs":["https:\/\/www.facebook.com\/tiabethcom","https:\/\/www.instagram.com\/raqueltiabeth","https:\/\/twitter.com\/https:\/\/www.twitter.com\/tiabethcom"]},{"@type":"WebSite","@id":"https:\/\/www.tiabeth.com.br\/#website","url":"https:\/\/www.tiabeth.com.br\/","name":"TiaBeth.com","description":"O maior conte\u00fado sobre diabetes da l\u00edngua portuguesa","publisher":{"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.tiabeth.com.br\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#primaryimage","url":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg","contentUrl":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg","width":1000,"height":650,"caption":"Prote\u00e7\u00e3o cardiovascular \u00e9 destaque do tratamento, segundo fabricante"},{"@type":"WebPage","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/","url":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/","name":"Anvisa aprova medicamento para diabetes - TiaBeth.com","isPartOf":{"@id":"https:\/\/www.tiabeth.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#primaryimage"},"datePublished":"2018-08-22T01:28:21+00:00","dateModified":"2018-08-22T01:28:21+00:00","breadcrumb":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.tiabeth.com.br\/"},{"@type":"ListItem","position":2,"name":"Anvisa aprova medicamento para diabetes"}]},{"@type":"Article","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#article","isPartOf":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/"},"author":{"name":"nlimonge","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b"},"headline":"Anvisa aprova medicamento para diabetes","datePublished":"2018-08-22T01:28:21+00:00","dateModified":"2018-08-22T01:28:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/"},"wordCount":315,"commentCount":0,"publisher":{"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982"},"image":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2018\/08\/ozempic.jpg","keywords":["diabetes","inje\u00e7\u00e3o","ozempic","tipo 2","tratamento"],"articleSection":[".Not\u00edcia","Medicamento","Tipo 2"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.tiabeth.com.br\/index.php\/2018\/08\/21\/anvisa-aprova-medicamento-para-diabetes\/#respond"]}]},{"@type":"Person","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b","name":"nlimonge","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g","caption":"nlimonge"},"url":"https:\/\/www.tiabeth.com.br\/index.php\/author\/nlimonge\/"}]}},"_links":{"self":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/posts\/19061"}],"collection":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/comments?post=19061"}],"version-history":[{"count":0,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/posts\/19061\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/media\/19062"}],"wp:attachment":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/media?parent=19061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/categories?post=19061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/tags?post=19061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}